We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Paper in leading Journal

30 Nov 2018 07:00

RNS Number : 9782I
DeepMatter Group PLC
30 November 2018
 

30 November 2018

DeepMatter Group plc

("DeepMatter", or the "Group")

 

Publication of Paper in Science

 

DeepMatter, the AIM-listed company focusing on digitizing chemistry, announces that its founding scientific director, Professor Lee Cronin, and his colleagues at the University of Glasgow have today published a paper in Science, a leading international journal. DeepMatter has rights to intellectual property arising from the laboratory of Professor Cronin as part of its Intellectual Property and Royalty agreement with the University of Glasgow.

 

The paper describes for the first time a method of molecule production which uses downloadable 'blueprints' to easily and reliably synthesise chemicals, such as drug molecules, automatically via a programmable chemical-robot: a 'Chemputer'. The idea of the 'Chemputer' is underpinned by a universal and interoperable standard for writing and sharing chemical recipes, developed by the University of Glasgow team. A number of the scientific concepts detailed in this paper make up a critical part of DeepMatter's commercial strategy.

 

DeepMatter has used its own universal and interoperable standard for writing and sharing chemical recipes as part of its DigitalGlassware™ platform. Currently, the platform allows experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. It is designed to enable scientists to work together effectively, sharing the details of their experiments in real time from anywhere so that work is not needlessly duplicated, time and money wasted, and ultimately so that new discoveries may be made faster.

 

DeepMatter's long term goal is to use DigitalGlassware™ to control robotics and to ultimately progress towards a commercially viable Chemputer™. In 2017, as part of its strategy to build its commercial market presence for the digitization of chemistry, DeepMatter registered the trademark for the Chemputer™ brand.

 

The full scientific Paper, 'Organic synthesis in a modular robotic system driven by a chemical programming language' can be found at www.sciencemag.org

 

Mark Warne, CEO of DeepMatter, commented:

 

"We are very pleased to see the work of our founding scientific director published in Science today. The recognition of such an esteemed publication demonstrates the significance of both the University of Glasgow's important research and our work here at DeepMatter, translating these advances into a commercially viable strategy.

 

"We believe that these developments can truly disrupt the way in which process and discovery chemistry is carried out today, bringing huge financial benefits to those working in these industries. We are very pleased to have the first stage of the DigitalGlasswareTM launch underway and look forward to continuing to educate chemists worldwide as to the benefits of using the platform."

 

For further information:

 

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

 

Stockdale Securities Limited

 

T: 020 7601 6100

Tom Griffiths

Edward Thomas

 

 

 

Alma PR

Caroline Forde

Rebecca Sanders-Hewett

Susie Hudson

 

T: 020 3405 0209

deepmatter@almapr.co.uk

 

About DeepMatter:

 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors.

 

The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

 

More information is available here: http://www.deepmattergroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPFNAELPFFF
Date   Source Headline
14th Jun 20127:00 amRNSBusiness Development Agreement
29th May 20124:03 pmRNSAGM Statement
25th Apr 20127:00 amRNSPreliminary Results - Commercialisation Underway
24th Feb 20127:00 amRNSAnti-Reflective Technology Development
26th Jan 20122:55 pmRNSHolding(s) in Company
3rd Jan 201212:16 pmRNSHolding(s) in Company
17th Oct 20117:00 amRNSAppointment of Chairman
30th Sep 20117:00 amRNSInterim Results
9th Aug 201110:30 amRNSIndustry leading Anti-Reflective Coating
16th Jun 20119:53 amRNSAnnual Financial Report
21st Apr 20117:00 amRNSJapan Agent Appointed
30th Mar 20117:05 amRNSDirectorate Change
30th Mar 20117:00 amRNSAnnual Financial Report
25th Feb 20117:00 amRNSDirectorate Change
27th Jan 201112:44 pmRNSHolding(s) in Company
24th Jan 20111:18 pmRNSHolding(s) in Company
2nd Dec 20107:00 amRNSTrading Update
30th Nov 20107:00 amRNSOAS delivers key process
29th Sep 20107:00 amRNSInterim results
27th Sep 20101:52 pmRNSHolding(s) in Company
14th Jul 201011:23 amRNSHolding(s) in Company
24th Jun 201011:19 amRNSHolding(s) in Company
16th Jun 20104:31 pmRNSHolding(s) in Company
4th Jun 20103:36 pmRNSHolding(s) in Company
2nd Jun 201010:06 amRNSHolding(s) in Company
28th May 20103:14 pmRNSHolding(s) in Company
25th May 20102:26 pmRNSResult of AGM
7th May 201012:49 pmRNSChange of Adviser
28th Apr 20107:00 amRNSFinal Results
16th Feb 20102:55 pmRNSHolding(s) in Company
12th Feb 201012:59 pmRNSHolding(s) in Company
12th Feb 20107:00 amRNSNotification of Interest
9th Feb 20108:58 amRNSDirectorate Change
4th Jan 20107:00 amRNSDirectorate Change
2nd Dec 200910:13 amRNSAward of Options
25th Sep 20097:00 amRNSDirectorate Change and Interim Results
29th May 20093:37 pmRNSAward of Share Options
22nd May 20099:45 amRNSAGM Statement
27th Apr 20097:00 amRNSPreliminary Results
16th Apr 20094:32 pmRNSNotice of AGM
7th Jan 200911:30 amRNSResignation of Director
18th Dec 200810:59 amRNSAward of Share Options
19th Nov 20087:00 amRNSDirectorate Change
11th Nov 20082:48 pmRNSChange of Auditor
30th Oct 20087:00 amRNSHolding(s) in Company
16th Oct 20087:00 amRNSBusiness Update & new Development Agreement signed
15th Oct 20084:34 pmRNSHolding(s) in Company
29th Sep 20087:00 amRNSInterim Results
9th Sep 20081:51 pmRNSHolding(s) in Company
1st Aug 20087:00 amRNSFundraising and Appointment o

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.